TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33835414

Group type: EXPERIMENTAL
Intervention: ReQoL-UI/10
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: EQ-5D-5L (VSE/cross-walk scores)
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: EQ-5D-5L (VSE)
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: ReQoL-10
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: ReQoL-UI
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: EQ-5D-5L
Number of subjects: 361
Study: 35346229

Group type: EXPERIMENTAL
Intervention: High Personalisation (HP) - access to ‘BBB’ website, video coaching sessions, text message support
Number of subjects: 83

Group type: COMPARATOR
Intervention: Medium Personalisation (MP) - website and text message support
Number of subjects: 83

Group type: COMPARATOR
Intervention: Low Personalisation (LP) - website only
Number of subjects: 83
Study: 33626290

Group type: EXPERIMENTAL
Intervention: Dengue vaccine booster
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32450831

Group type: EXPERIMENTAL
Intervention: Ingestion of carbosulfan or profenofos
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: Ingestion of pesticides
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: Trend analysis of carbosulfan and profenofos
Number of subjects: 337
Study: 35797300

Group type: EXPERIMENTAL
Intervention: Permethrin 5% and Fusidic acid 2% cream
Number of subjects: 40

Group type: COMPARATOR
Intervention: Permethrin 5% and placebo
Number of subjects: 40
Study: 34054104

Group type: EXPERIMENTAL
Intervention: 4‐μg E2 vaginal insert
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 10‐μg E2 vaginal insert
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 32762415

Group type: EXPERIMENTAL
Intervention: Pembrolizumab (first-line treatment)
Number of subjects: 302
Study: 35641166

Group type: EXPERIMENTAL
Intervention: Intrathecal (IT) transplantation of mesenchymal stem cells (MSC)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Intravenous (IV) transplantation of mesenchymal stem cells (MSC)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (sham treatment)
Number of subjects: 48
Study: 34377204

Group type: EXPERIMENTAL
Intervention: Intravenous eptifibatide before angioplasty with heparin
Number of subjects: 104

Group type: COMPARATOR
Intervention: Coronary angioplasty with heparin
Number of subjects: 104
Study: 32047021

Group type: EXPERIMENTAL
Intervention: Operative management
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-operative management
Number of subjects: 0
Study: 36034460

Group type: EXPERIMENTAL
Intervention: LH-based modified GnRH antagonist protocol
Number of subjects: 372

Group type: COMPARATOR
Intervention: Conventional flexible GnRH antagonist protocol
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Both protocols
Number of subjects: 372
Study: 34351363

Group type: EXPERIMENTAL
Intervention: 24-week multicomponent intervention
Number of subjects: 383

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 383
Study: 33238932

Group type: EXPERIMENTAL
Intervention: Mindfulness oriented intervention (6 weeks of mindfulness training combined with interactive drug education)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (health training combined with the same education)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Mindfulness oriented intervention
Number of subjects: 82
Study: 35421939

Group type: EXPERIMENTAL
Intervention: CMR-guided workflow
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: CMR-aided workflow
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard EAM-guided VT ablation
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: CMR-guided vs CMR-aided approaches
Number of subjects: 100
Study: 34755786

Group type: EXPERIMENTAL
Intervention: Bonded Spurs (BS)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Chincup (CC)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Fixed Palatal Crib (FPC)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Removable Palatal Crib (RPC)
Number of subjects: 63
Study: 33050586

Group type: EXPERIMENTAL
Intervention: 320 mg of Fermented Porcine Placental Extract (FPP) once daily
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 35037125

Group type: EXPERIMENTAL
Intervention: Rocuronium
Number of subjects: 1226

Group type: COMPARATOR
Intervention: Succinylcholine
Number of subjects: 1226

Group type: EXPERIMENTAL
Intervention: BMI > 30 kg/m2
Number of subjects: 1226

Group type: EXPERIMENTAL
Intervention: SpO2 < 90% before intubation
Number of subjects: 1226

Group type: EXPERIMENTAL
Intervention: Intubation Difficulty Score > 5
Number of subjects: 1226

Group type: EXPERIMENTAL
Intervention: Post-intubation hypoxaemia
Number of subjects: 1226

Group type: EXPERIMENTAL
Intervention: Post-intubation hypotension
Number of subjects: 1226

Group type: EXPERIMENTAL
Intervention: Pulmonary aspiration
Number of subjects: 1226
Study: 34117637

Group type: EXPERIMENTAL
Intervention: Study medication (specifics not provided)
Number of subjects: 22
Study: 36327514

Group type: EXPERIMENTAL
Intervention: Binaural music (BM)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Non-binaural music (NBM)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard care (C)
Number of subjects: 60
Study: 33397282

Group type: EXPERIMENTAL
Intervention: Improved cookstove intervention
Number of subjects: 2031

Group type: COMPARATOR
Intervention: Traditional cookstove method (Control)
Number of subjects: 2031
Study: 35644753

Group type: EXPERIMENTAL
Intervention: Integrated collaborative care intervention
Number of subjects: 75

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 75
Study: 34283660

Group type: EXPERIMENTAL
Intervention: Higher-load intensity RT (HIRT, n = 20, 8-12 repetition maximum)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lower-load intensity RT (LIRT, n = 20, 30-35 repetition maximum)
Number of subjects: 40
Study: 32212806

Group type: EXPERIMENTAL
Intervention: Lavender essential oil on a cotton ball
Number of subjects: 80

Group type: COMPARATOR
Intervention: Distilled water on a cotton ball (Control)
Number of subjects: 80
Study: 35636937

Group type: EXPERIMENTAL
Intervention: 5 mg of melatonin prolonged-release oral capsules
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34535840

Group type: EXPERIMENTAL
Intervention: Hyaluronic matrix and xenograft
Number of subjects: 13

Group type: COMPARATOR
Intervention: Xenograft
Number of subjects: 13
Study: 32689975

Group type: EXPERIMENTAL
Intervention: Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) single tablet regimen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Boosted protease-inhibitor (bPI) regimen
Number of subjects: 0
Study: 34831613

Group type: EXPERIMENTAL
Intervention: CReSS device measuring smoking topography (ST) in naturalistic settings for two weeks with five days of device usage.
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: CReSS device
Number of subjects: 43
Study: 33444178

Group type: EXPERIMENTAL
Intervention: 8-week group art therapy intervention
Number of subjects: 240

Group type: COMPARATOR
Intervention: 8-week Mandala colouring comparison group
Number of subjects: 240
Study: 35886420

Group type: EXPERIMENTAL
Intervention: Computerised reminder system
Number of subjects: 506

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 506
Study: 34517195

Group type: EXPERIMENTAL
Intervention: High neutrophil-to-lymphocyte ratio (NLR > 2.2)
Number of subjects: 2104

Group type: EXPERIMENTAL
Intervention: Presence of brain metastases (BM)
Number of subjects: 2104
Study: 36027380

Group type: EXPERIMENTAL
Intervention: Short-acting RAS blockers taken on awakening
Number of subjects: 105

Group type: COMPARATOR
Intervention: Short-acting RAS blockers taken at bedtime
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Aldosterone breakthrough (AB)
Number of subjects: 105
Study: 33410611

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 555

Group type: COMPARATOR
Intervention: Combined volatile anesthetics (sevoflurane and desflurane)
Number of subjects: 555
Study: 37759290

Group type: EXPERIMENTAL
Intervention: Automated Insulin Delivery (AID) devices
Number of subjects: 2376
Study: 34459968

Group type: EXPERIMENTAL
Intervention: Antenatal corticosteroids (ACS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33884645

Group type: EXPERIMENTAL
Intervention: Trophic enteral feeding (20 ml/h) via a nasogastric tube, in addition to standard care.
Number of subjects: 87

Group type: COMPARATOR
Intervention: Standard nutrition care (parenteral nutrition).
Number of subjects: 87
Study: 33837106

Group type: EXPERIMENTAL
Intervention: Fiasp
Number of subjects: 220

Group type: COMPARATOR
Intervention: NovoRapid
Number of subjects: 220
Study: 32138596

Group type: EXPERIMENTAL
Intervention: Compression garments (COMP)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Loose-fitting clothing (CON)
Number of subjects: 30
Study: 35720885

Group type: EXPERIMENTAL
Intervention: Laparoscopic treatment (observation group)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Open surgical treatment (control group)
Number of subjects: 64
Study: 34742140

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32648508

Group type: EXPERIMENTAL
Intervention: PDE‐5 inhibitors (PDE‐5i)
Number of subjects: 13772

Group type: COMPARATOR
Intervention: No PDE‐5 inhibitors (no PDE‐5i)
Number of subjects: 13772
Study: 36447250

Group type: EXPERIMENTAL
Intervention: Action Observation Therapy (AOT) combined with eccentric exercises
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nature videos before performing eccentric exercises (Control)
Number of subjects: 30
Study: 33865711

Group type: EXPERIMENTAL
Intervention: FABIB score (high FABIB scores ≥6)
Number of subjects: 297

Group type: COMPARATOR
Intervention: Clavien-Dindo Classification (grade III + IV)
Number of subjects: 297
Study: 35659064

Group type: EXPERIMENTAL
Intervention: 125 mg oleoylethanolamide (OEA) capsule daily for 8 weeks
Number of subjects: 46

Group type: COMPARATOR
Intervention: 125 mg capsule containing wheat flour (placebo) daily for 8 weeks
Number of subjects: 46
Study: 32228468

Group type: EXPERIMENTAL
Intervention: Baseline slow gait speed
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Incident slow gait speed at 18 months
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Cognitive severity at baseline
Number of subjects: 369
Study: 34045217

Group type: EXPERIMENTAL
Intervention: Medication review at hospital discharge combined with communication stimulus between hospital physicians and general practitioners
Number of subjects: 612

Group type: COMPARATOR
Intervention: Control group not explicitly mentioned
Number of subjects: 612
Study: 32237922

Group type: EXPERIMENTAL
Intervention: Cranberry supplement (288 mg equivalent to 26 g of dried cranberry)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 34358756

Group type: EXPERIMENTAL
Intervention: CBM‐IClin (Cognitive Bias Modification-Interpretation program)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 121
Study: 33051212

Group type: EXPERIMENTAL
Intervention: Therapist led outpatient rehabilitation (18 sessions over six weeks)
Number of subjects: 334

Group type: COMPARATOR
Intervention: Home exercise based protocol (physiotherapy review followed by home exercises)
Number of subjects: 334
Study: 35703569

Group type: EXPERIMENTAL
Intervention: Homemade orange corn-soybean flour (H-CSB)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Orange corn-common bean flour (CCBB)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Commercial corn-soybean flour (C-CSB)
Number of subjects: 101
Study: 32959182

Group type: EXPERIMENTAL
Intervention: 3D HD
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 4K HD
Number of subjects: 21

Group type: COMPARATOR
Intervention: 2D HD
Number of subjects: 21
Study: 32861156

Group type: EXPERIMENTAL
Intervention: Multiple locus variable number tandem repeat analysis (MLVA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Capsular typing by wzi gene sequencing
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: MLVA
Number of subjects: 60

Group type: COMPARATOR
Intervention: wzi gene sequencing
Number of subjects: 60
Study: 36307862

Group type: EXPERIMENTAL
Intervention: STARC-SUD (Skills Training in Affect Regulation - a Culture-sensitive approach)
Number of subjects: 286
Study: 32803820

Group type: EXPERIMENTAL
Intervention: SMS reminder group
Number of subjects: 2225

Group type: COMPARATOR
Intervention: Standard care group
Number of subjects: 2225
Study: 35320892

Group type: EXPERIMENTAL
Intervention: Olaparib 200mg bid + Cediranib 30mg qd (arm 1)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Olaparib 300mg bid + Durvalumab 1,500mg q4w (arm 2)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Durvalumab 1,500 mg q4w + Pegylated liposomal doxorubicin (PLD) or Topotecan or Weekly Paclitaxel (arm 3)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Durvalumab 1,500 mg q4w + Tremelimumab 75mg q4w + PLD or Topotecan or Weekly Paclitaxel (arm 4)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Durvalumab 1,500 mg q4w + Tremelimumab 300mg [1 dose] + Weekly Paclitaxel [60 mg/m² D1,8,15 q4w for 4 cycles] (arm 5)
Number of subjects: 70
Study: 32752077

Group type: EXPERIMENTAL
Intervention: Low FODMAP diet
Number of subjects: 27

Group type: COMPARATOR
Intervention: NICE diet
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 27
Study: 35114331

Group type: EXPERIMENTAL
Intervention: Standard Oral Hygiene Advice (OHA) with intra-oral camera (IOC) images
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard Oral Hygiene Advice (OHA)
Number of subjects: 22
Study: 33549723

Group type: EXPERIMENTAL
Intervention: Early ACL reconstruction (ACLR)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Optional delayed ACLR
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Early ACLR
Number of subjects: 121

Group type: COMPARATOR
Intervention: Rehabilitation alone
Number of subjects: 121
Study: 34158427

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate 15 mg/kg (Group M)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Normal saline (Group N)
Number of subjects: 132
Study: 35970278

Group type: EXPERIMENTAL
Intervention: 1 g of IV tranexamic acid preoperatively
Number of subjects: 100

Group type: COMPARATOR
Intervention: No tranexamic acid (control group)
Number of subjects: 100
Study: 33079265

Group type: EXPERIMENTAL
Intervention: Severely obese adolescents with LVH (n=24, 55.8%)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Left ventricular mass index
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Interventricular septum thickness (IVST)
Number of subjects: 43
Study: 35444271

Group type: EXPERIMENTAL
Intervention: Intensive weight-loss intervention (9 contact points in 6 months)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Intensive weight-loss intervention
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 140
Study: 32894873

Group type: EXPERIMENTAL
Intervention: Delegation Agreement (D-A) implementation
Number of subjects: 30
Study: 33991337

Group type: EXPERIMENTAL
Intervention: Topical application of diesel exhaust particles (DEP) at nontoxic concentrations
Number of subjects: 76

Group type: COMPARATOR
Intervention: Topical application of an antioxidant mixture
Number of subjects: 76
Study: 32432487

Group type: EXPERIMENTAL
Intervention: Intervention (education around infant crying and abusive head trauma)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (non-US-born mothers)
Number of subjects: 0
Study: 35054157

Group type: EXPERIMENTAL
Intervention: Liposomal fat-soluble vitamin formulation containing vitamin K2 (2667 IU vitamin A, 1333 IU beta-carotene, 4000 IU D3, 150 IU E, 2 mg K1, 400 μg K2)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Liposomal fat-soluble vitamin formulation containing vitamin K2
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard vitamin preparations (2500 IU vitamin A, 1428 IU beta-carotene, 4000 IU D3, 150 IU E, 2.14 mg K1)
Number of subjects: 100
Study: 33049119

Group type: EXPERIMENTAL
Intervention: Nebulized ipratropium bromide (500 µg in 0.9% saline per dose)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (nebulized 0.9% saline)
Number of subjects: 30
Study: 35064811

Group type: EXPERIMENTAL
Intervention: Eccentric Nordic Hamstring Exercise (NHE) training
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (regular handball training without NHE)
Number of subjects: 23
Study: 33857858

Group type: EXPERIMENTAL
Intervention: Household incentives with Community‐Led Total Sanitation (CLTS)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Village incentives with Community‐Led Total Sanitation (CLTS)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Improved sanitation coverage
Number of subjects: 160

Group type: COMPARATOR
Intervention: No subsidy with Community‐Led Total Sanitation (CLTS)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Both household and village incentives with Community‐Led Total Sanitation (CLTS)
Number of subjects: 160
Study: 33762240

Group type: EXPERIMENTAL
Intervention: EE information plus standard care (INT)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Standard weight management care (SC)
Number of subjects: 105
Study: 33185345

Group type: EXPERIMENTAL
Intervention: Sildenafil spray (50 mg) on an empty stomach
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sildenafil tablet (50 mg) on an empty stomach
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Sildenafil spray (50 mg) after a meal
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sildenafil tablet (50 mg) after a meal
Number of subjects: 50
Study: 35100025

Group type: EXPERIMENTAL
Intervention: Robot-mediated virtual reality gaming + conventional physiotherapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 40
Study: 33420114

Group type: EXPERIMENTAL
Intervention: 2-dose regimen of hepatitis A vaccine (0, 6 months)
Number of subjects: 116

Group type: COMPARATOR
Intervention: 3-dose regimen of hepatitis A vaccine (0, 1, 6 months)
Number of subjects: 116
Study: 32368869

Group type: EXPERIMENTAL
Intervention: Lenabasum (cannabinoid type 2 receptor agonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34250931

Group type: EXPERIMENTAL
Intervention: Motor imagery-based rehabilitation (MIG)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conventional rehabilitation (CG)
Number of subjects: 29
Study: 34145734

Group type: EXPERIMENTAL
Intervention: Dietary counselling at four routine visits focusing on dietary fat, fibre, and saccharose intake
Number of subjects: 399

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 399
Study: 33414363

Group type: EXPERIMENTAL
Intervention: Trauma-focused cognitive behavior therapy (TF-CBT)
Number of subjects: 36
Study: 32967439

Group type: EXPERIMENTAL
Intervention: Telephone follow-up (nurse or pharmacist)
Number of subjects: 2091

Group type: COMPARATOR
Intervention: Clinic follow-up (physician)
Number of subjects: 2091
Study: 35129519

Group type: EXPERIMENTAL
Intervention: No touch technique
Number of subjects: 853

Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 853
Study: 33690245

Group type: EXPERIMENTAL
Intervention: Fully automated pulsating support system air mattress used for 30 days in the prevention group (n = 22)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Fully automated pulsating support system air mattress used for 30 days in the treatment group (n = 18)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Comfort assessment of the mattress by caregivers, family members, and residents
Number of subjects: 40
Study: 32969007

Group type: EXPERIMENTAL
Intervention: Blended training (didactic and hands-on)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Didactic training only
Number of subjects: 43
Study: 36173596

Group type: EXPERIMENTAL
Intervention: Colchicine (1-1.5 mg/day for 3 days, then 0.5 mg/day for 11 days) and Prednisone (60 mg/day for 3 days)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Colchicine/Prednisone
Number of subjects: 54

Group type: COMPARATOR
Intervention: Standard treatment (intravenous dexamethasone)
Number of subjects: 54
Study: 35361560

Group type: EXPERIMENTAL
Intervention: Intermittent fasting (water-only 24-h fasting twice-per-week for 4 weeks and once-per-week for 22 weeks)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control (ad libitum energy intake)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Intermittent fasting
Number of subjects: 67
Study: 32784845

Group type: EXPERIMENTAL
Intervention: Carrying police equipment (≈3.5 kg)
Number of subjects: 275
Study: 35793700

Group type: EXPERIMENTAL
Intervention: HPV‐Screening protocol
Number of subjects: 302295

Group type: COMPARATOR
Intervention: LBC‐Screening protocol
Number of subjects: 302295
Study: 34223671

Group type: EXPERIMENTAL
Intervention: Atrial fibrillation (AF) as the prevailing rhythm
Number of subjects: 150

Group type: COMPARATOR
Intervention: Sinus rhythm
Number of subjects: 150
Study: 32659313

Group type: EXPERIMENTAL
Intervention: DBV712 250 μg (epicutaneous immunotherapy)
Number of subjects: 141
Study: 34428630

Group type: EXPERIMENTAL
Intervention: Counselling for Alcohol Problems (CAP) & enhanced usual care (EUC)
Number of subjects: 512

Group type: COMPARATOR
Intervention: Enhanced usual care (EUC) only
Number of subjects: 512
Study: 34604692

Group type: EXPERIMENTAL
Intervention: Biofortified pearl millet
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sweet potato or sweet potato + pulse
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Multiple crop combinations of biofortified crops
Number of subjects: 11
Study: 35817694

Group type: EXPERIMENTAL
Intervention: Intraoperative cholangiography (IOC)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Magnetic resonance cholangiopancreatography (MRCP)
Number of subjects: 122
Study: 33373017

Group type: EXPERIMENTAL
Intervention: Radial artery access
Number of subjects: 80

Group type: COMPARATOR
Intervention: Femoral artery access
Number of subjects: 80
Study: 34264001

Group type: EXPERIMENTAL
Intervention: Laparoscopic sacropexy (LS)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Transvaginal mesh (TVM)
Number of subjects: 220
Study: 32275028

Group type: EXPERIMENTAL
Intervention: GA with HTE (HTE group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: GA alone (GA group)
Number of subjects: 80